Home » Newsletters » BioWorld Science

BioWorld Science

June 2, 2017

View Archived Issues

DUSP1 identified as a therapeutic target for pulmonary fibrotic diseases

Ionis Pharmaceuticals' Spinraza approved in E.U. for spinal muscular atrophy

Eleven Biotherapeutics cleared to continue phase III study of Vicinium

Achaogen begins clinical development program of C-Scape

Novel missense mutation in PLEC gene tied to atrial fibrillation

Genentech files regulatory submissions to begin phase I studies of BL-8040 plus atezolizumab

Inovio Pharmaceuticals enters immuno-oncology collaboration with Genentech

Targeting CD98 shrinks malignant mesothelioma tumors in vivo

Orexo receives milestone payment triggered by OX-CLI phase I initiation

The University of Florida and Torrey Pines Institute patent alpha-enolase inhibitors

The University of Rochester presents bortezomib conjugates

Reata reports data from part 1 of phase II MOXIe trial of omaveloxolone in Friedreich's ataxia

Incyte identifies PI3Kgamma inhibitors

Voyager Therapeutics selects Huntington's disease clinical candidate

Mirati Therapeutics divulges LSD1 inhibitors

Biomarin Pharmaceutical wins E.U. approval of Brineura for CLN2

Thetis Pharmaceuticals discloses amino acid salts of saturated fatty acids

Deciphera closes series C financing to support development of oncology products

Vaxon Biotech reports results from phase IIb study of VX-001 cancer vaccine

Novel pyrazolopyridine KDU-731 a candidate for treating cryptosporidiosis

Ligand Pharmaceuticals, Surface Oncology enter OmniAb license agreement

U.S. and E.U. submissions made for dolutegravir/rilpivirine single-tablet regimen for HIV-1

DOCK6 gene found to be involved in ciliopathies

GHIT Fund secures over USD 200 million in commitments for second phase replenishment

FDA approves Roche's companion diagnostic for Zykadia

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 28, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...